Characteristic | No. | % |
---|---|---|
Age at treatment (years) | ||
Median (range) | 63 (34–82) | |
Interquartile range | 57–69 | |
Gender | ||
Male | 21 | 15 |
Female | 123 | 85 |
Site of primary tumour | ||
Ovary | 101 | 70 |
Fallopian tube | 8 | 6 |
Peritoneum | 5 | 3 |
Lung | 27 | 19 |
Uterus | 2 | 1 |
Breast | 1 | 1 |
Tumour stage | ||
I | 15 | 10 |
II | 8 | 6 |
III | 83 | 58 |
IV | 38 | 26 |
Paclitaxel+carboplatin treatment* | ||
Median number cycles (range) | 6 (2–9) | |
Chemotherapy administered previously | 9 | 6 |
Neurotoxic drugs administered previously† | 6 | 4 |
*Paclitaxel 175 mg/m2+carboplatin 5–6 AUC every 21 days.
†Median of 34 weeks before paclitaxel chemotherapy (range 4–364 weeks).